United States · FDA National Drug Code directory
Ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8692_0967063c-d31b-41d5-90ec-aefd12e7a327
- Product NDC
- 68788-8692
- Form
- TABLET
- Composition / generic term
- Ciprofolxacin
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240610
- Source listing expiry
- 20271231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE (68788-8692-0) · 68788-8692-0
- 14 TABLET in 1 BOTTLE (68788-8692-1) · 68788-8692-1
- 20 TABLET in 1 BOTTLE (68788-8692-2) · 68788-8692-2
- 30 TABLET in 1 BOTTLE (68788-8692-3) · 68788-8692-3
- 10 TABLET in 1 BOTTLE (68788-8692-8) · 68788-8692-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →